Systemic treatment of advanced hepatocellular cancer: new hope on the horizon

Rachael Chang Lee1, Niall Tebbutt1

  • 1a Department of Medical Oncology , Olivia Newton-John Cancer Wellness and Research Centre , Heidelberg , Australia.

Abstract

Insights

New targeted therapies have significantly improved outcomes for advanced hepatocellular carcinoma (HCC) patients. Sequential treatments combining targeted agents and immunotherapy offer better prognoses for advanced HCC, with ongoing research into novel combinations and personalized medicine.

Area of Science:

  • Hepatology
  • Oncology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
  • Many patients are diagnosed at advanced stages, precluding locoregional treatments.
  • Sorafenib was the sole treatment for advanced HCC for many years.

Purpose of the Study:

  • To review current systemic treatment options for advanced HCC in patients ineligible for locoregional therapy.
  • To discuss future prospects in advanced HCC management.

Main Methods:

  • This is a review article.
  • It summarizes current systemic therapies and future directions.
  • Expert opinion is included.

Main Results:

  • New targeted therapeutics have transformed advanced HCC treatment.
  • Sequential therapies (sorafenib/lenvatinib first-line, immunotherapy/regorafenib/cabozantinib second-line) improve outcomes.
  • Novel combinations and biomarkers are under investigation.

Conclusions:

  • Advanced HCC treatment has significantly improved due to new systemic therapies.
  • Personalized treatment approaches considering etiology and molecular factors are crucial.
  • Further research into novel combinations and biomarkers is warranted.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Schwarzschild Radius and Event Horizon01:21

Schwarzschild Radius and Event Horizon

No object with a finite mass can travel faster than the speed of light in a vacuum. This fact has an interesting consequence in the domain of extremely high gravitational fields.
The minimum speed required to launch a projectile from the surface of an object to which it is gravitationally bound so that it eventually escapes the object’s gravitational field is called the escape velocity. The escape velocity is independent of the mass of the object. Merging the idea of escape...
2.7K
Overview of Advanced Functional Groups02:22

Overview of Advanced Functional Groups


Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.7K
Second Order systems II01:18

Second Order systems II

In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
406
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
First Order Systems01:21

First Order Systems

First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
426